Bonnavion, Remy Pharmacology, Max Planck Institute for Heart and Lung Research, Max Planck Society;
Teinturier, R., Luo, Y., Decaussin-Petrucci, M., Vlaeminck-Guillem, V., Vacherot, F., Firlej, V., et al. (2020). Men1 disruption in Nkx3.1-deficient mice results in AR(low)/CD44(+) microinvasive carcinoma development with the dysregulated AR pathway. ONCOGENE. doi:10.1038/s41388-020-01589-1.